nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—atherosclerosis	0.775	1	CbGaD
Mimosine—CCL2—tunica intima—atherosclerosis	0.0233	0.377	CbGeAlD
Mimosine—CCL2—artery—atherosclerosis	0.00796	0.129	CbGeAlD
Mimosine—CCL2—endothelium—atherosclerosis	0.00673	0.109	CbGeAlD
Mimosine—CCL2—blood vessel—atherosclerosis	0.0062	0.101	CbGeAlD
Mimosine—CCL2—connective tissue—atherosclerosis	0.00318	0.0515	CbGeAlD
Mimosine—TYR—liver—atherosclerosis	0.00298	0.0483	CbGeAlD
Mimosine—CCL2—cardiovascular system—atherosclerosis	0.00277	0.0448	CbGeAlD
Mimosine—SHMT1—adipose tissue—atherosclerosis	0.00263	0.0427	CbGeAlD
Mimosine—CCL2—Simvastatin—Lovastatin—atherosclerosis	0.00255	0.5	CbGdCrCtD
Mimosine—CCL2—Simvastatin—Pravastatin—atherosclerosis	0.00255	0.5	CbGdCrCtD
Mimosine—CCL2—adipose tissue—atherosclerosis	0.00244	0.0395	CbGeAlD
Mimosine—SHMT1—liver—atherosclerosis	0.00185	0.0299	CbGeAlD
Mimosine—CCL2—liver—atherosclerosis	0.00171	0.0277	CbGeAlD
Mimosine—CCL2—GPCR ligand binding—CCL4—atherosclerosis	0.000285	0.0018	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—NFKB1—atherosclerosis	0.000283	0.00179	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—NFKB1—atherosclerosis	0.00028	0.00177	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL6—atherosclerosis	0.000279	0.00177	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atherosclerosis	0.000279	0.00177	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK8—atherosclerosis	0.000278	0.00176	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAPK3—atherosclerosis	0.000278	0.00176	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—ICAM1—atherosclerosis	0.000277	0.00176	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—NOS2—atherosclerosis	0.000275	0.00174	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—CXCL8—atherosclerosis	0.000273	0.00173	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MMP9—atherosclerosis	0.00027	0.00171	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—TNF—atherosclerosis	0.000267	0.00169	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000267	0.00169	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TNF—atherosclerosis	0.000263	0.00166	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—VEGFA—atherosclerosis	0.000257	0.00163	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000256	0.00162	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000255	0.00162	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—STAT3—atherosclerosis	0.000254	0.00161	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—UTS2—atherosclerosis	0.000254	0.00161	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—IL6—atherosclerosis	0.000252	0.0016	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—EDN1—atherosclerosis	0.000248	0.00157	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL5—atherosclerosis	0.000246	0.00156	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CX3CR1—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CASR—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK3—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CX3CL1—atherosclerosis	0.000239	0.00151	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000238	0.00151	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—atherosclerosis	0.000232	0.00147	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000231	0.00146	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000231	0.00146	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LDLRAP1—atherosclerosis	0.000227	0.00144	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CNR2—atherosclerosis	0.000226	0.00143	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000225	0.00143	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000222	0.00141	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000222	0.00141	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TNF—atherosclerosis	0.000218	0.00138	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL6—atherosclerosis	0.000216	0.00137	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—NFKB1—atherosclerosis	0.000214	0.00136	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLTP—atherosclerosis	0.000214	0.00135	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL6—atherosclerosis	0.000212	0.00134	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IFNG—atherosclerosis	0.000211	0.00134	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK8—atherosclerosis	0.000211	0.00133	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—PLA2G7—atherosclerosis	0.000206	0.00131	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—AGT—atherosclerosis	0.000206	0.0013	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—PTGS2—atherosclerosis	0.000202	0.00128	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRH1—atherosclerosis	0.000202	0.00128	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000198	0.00125	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000196	0.00124	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CXCL8—atherosclerosis	0.000196	0.00124	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL3—atherosclerosis	0.000194	0.00123	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—F2—atherosclerosis	0.00019	0.00121	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL1B—atherosclerosis	0.000188	0.00119	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—atherosclerosis	0.000187	0.00119	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LTA4H—atherosclerosis	0.000185	0.00117	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCG8—atherosclerosis	0.000185	0.00117	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK3—atherosclerosis	0.000184	0.00117	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MMP9—atherosclerosis	0.000178	0.00112	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—EDNRA—atherosclerosis	0.000176	0.00111	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR2—atherosclerosis	0.000176	0.00111	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL6—atherosclerosis	0.000176	0.00111	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—atherosclerosis	0.000173	0.00109	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GHRL—atherosclerosis	0.000171	0.00109	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—HSPD1—atherosclerosis	0.000168	0.00106	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL6—atherosclerosis	0.000167	0.00106	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—atherosclerosis	0.000167	0.00106	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000166	0.00105	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000165	0.00105	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—atherosclerosis	0.000164	0.00104	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOA4—atherosclerosis	0.000161	0.00102	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MAPK3—atherosclerosis	0.000151	0.000955	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—KNG1—atherosclerosis	0.00015	0.000953	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—AGTR1—atherosclerosis	0.00015	0.000947	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCG1—atherosclerosis	0.000146	0.000928	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TGFB1—atherosclerosis	0.000146	0.000927	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL4—atherosclerosis	0.000146	0.000925	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL6—atherosclerosis	0.000139	0.000883	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOA2—atherosclerosis	0.000139	0.00088	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000138	0.000875	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—FABP4—atherosclerosis	0.000138	0.000872	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LCAT—atherosclerosis	0.000138	0.000872	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—atherosclerosis	0.000137	0.000866	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—F7—atherosclerosis	0.000135	0.000857	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOA4—atherosclerosis	0.000135	0.000856	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IL6—atherosclerosis	0.000135	0.000852	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.000134	0.000849	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP7A1—atherosclerosis	0.000133	0.000841	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—UTS2—atherosclerosis	0.00013	0.000825	CbGpPWpGaD
Mimosine—SHMT1—Disease—BGN—atherosclerosis	0.000128	0.000813	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000128	0.000809	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—EDN1—atherosclerosis	0.000127	0.000803	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL5—atherosclerosis	0.000126	0.000797	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000125	0.000791	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CASR—atherosclerosis	0.000125	0.000791	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—atherosclerosis	0.000124	0.000786	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP27A1—atherosclerosis	0.000123	0.000777	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000122	0.000775	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—GHRL—atherosclerosis	0.000121	0.000763	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRH1—atherosclerosis	0.000119	0.000756	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ACE—atherosclerosis	0.000117	0.000739	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALOX5AP—atherosclerosis	0.000116	0.000737	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOA2—atherosclerosis	0.000116	0.000737	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLA2G2A—atherosclerosis	0.000116	0.000737	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALOX15—atherosclerosis	0.000116	0.000737	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CNR2—atherosclerosis	0.000116	0.000735	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCG5—atherosclerosis	0.000115	0.000728	CbGpPWpGaD
Mimosine—SHMT1—Disease—CST3—atherosclerosis	0.000112	0.000709	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LPA—atherosclerosis	0.000111	0.000703	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—atherosclerosis	0.00011	0.000699	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BGN—atherosclerosis	0.000107	0.000681	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOA5—atherosclerosis	0.000106	0.000674	CbGpPWpGaD
Mimosine—SHMT1—Disease—NAMPT—atherosclerosis	0.000106	0.000671	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—AGT—atherosclerosis	0.000105	0.000666	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—PLAUR—atherosclerosis	0.000105	0.000664	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOC3—atherosclerosis	0.000105	0.000663	CbGpPWpGaD
Mimosine—SHMT1—Disease—LDLR—atherosclerosis	0.000104	0.000659	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—PLG—atherosclerosis	0.000102	0.000649	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLA2G1B—atherosclerosis	0.000102	0.000649	CbGpPWpGaD
Mimosine—SHMT1—Disease—HSPA1B—atherosclerosis	0.0001	0.000636	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL3—atherosclerosis	9.98e-05	0.000632	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALOX5—atherosclerosis	9.89e-05	0.000627	CbGpPWpGaD
Mimosine—SHMT1—Disease—NCF1—atherosclerosis	9.73e-05	0.000616	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—F2—atherosclerosis	9.72e-05	0.000616	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOA4—atherosclerosis	9.36e-05	0.000593	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGF2—atherosclerosis	9.33e-05	0.000591	CbGpPWpGaD
Mimosine—SHMT1—Disease—CYBA—atherosclerosis	9.15e-05	0.000579	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—EDNRA—atherosclerosis	9.02e-05	0.000572	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR2—atherosclerosis	9.02e-05	0.000572	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	9e-05	0.00057	CbGpPWpGaD
Mimosine—SHMT1—Disease—PARP1—atherosclerosis	8.95e-05	0.000567	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NAMPT—atherosclerosis	8.87e-05	0.000562	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LIPC—atherosclerosis	8.82e-05	0.000558	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GHRL—atherosclerosis	8.79e-05	0.000557	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOC3—atherosclerosis	8.76e-05	0.000555	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LDLR—atherosclerosis	8.71e-05	0.000552	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL4—atherosclerosis	8.63e-05	0.000547	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CETP—atherosclerosis	8.51e-05	0.000539	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SCARB1—atherosclerosis	8.15e-05	0.000516	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOA2—atherosclerosis	8.06e-05	0.000511	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KNG1—atherosclerosis	7.72e-05	0.000489	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HMGCR—atherosclerosis	7.69e-05	0.000487	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—UTS2—atherosclerosis	7.69e-05	0.000487	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AGTR1—atherosclerosis	7.67e-05	0.000486	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MMP1—atherosclerosis	7.49e-05	0.000475	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—AGT—atherosclerosis	7.4e-05	0.000469	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CX3CR1—atherosclerosis	7.37e-05	0.000467	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASR—atherosclerosis	7.37e-05	0.000467	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—LEP—atherosclerosis	7.25e-05	0.000459	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CX3CL1—atherosclerosis	7.23e-05	0.000458	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCA1—atherosclerosis	6.86e-05	0.000434	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CNR2—atherosclerosis	6.85e-05	0.000434	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL8—atherosclerosis	6.85e-05	0.000434	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MMP3—atherosclerosis	6.84e-05	0.000433	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—F2—atherosclerosis	6.84e-05	0.000433	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOB—atherosclerosis	6.73e-05	0.000426	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—EDN1—atherosclerosis	6.5e-05	0.000412	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL5—atherosclerosis	6.45e-05	0.000409	CbGpPWpGaD
Mimosine—SHMT1—Disease—LPL—atherosclerosis	6.42e-05	0.000407	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKCG—atherosclerosis	6.25e-05	0.000396	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—INS—atherosclerosis	6.19e-05	0.000392	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PRKCG—atherosclerosis	6.14e-05	0.000389	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VWF—atherosclerosis	6.11e-05	0.000387	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOC3—atherosclerosis	6.07e-05	0.000385	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LDLR—atherosclerosis	6.03e-05	0.000382	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGF1—atherosclerosis	5.99e-05	0.00038	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL3—atherosclerosis	5.89e-05	0.000373	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HMOX1—atherosclerosis	5.88e-05	0.000373	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MMP2—atherosclerosis	5.8e-05	0.000367	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTHFR—atherosclerosis	5.78e-05	0.000366	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NCF1—atherosclerosis	5.64e-05	0.000358	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOB—atherosclerosis	5.64e-05	0.000357	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFB—atherosclerosis	5.63e-05	0.000357	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTM1—atherosclerosis	5.48e-05	0.000347	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AGT—atherosclerosis	5.4e-05	0.000342	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOE—atherosclerosis	5.39e-05	0.000341	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LPL—atherosclerosis	5.38e-05	0.000341	CbGpPWpGaD
Mimosine—SHMT1—Disease—CAV1—atherosclerosis	5.34e-05	0.000338	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EDNRA—atherosclerosis	5.33e-05	0.000338	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR2—atherosclerosis	5.33e-05	0.000338	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOA1—atherosclerosis	5.32e-05	0.000337	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CYBA—atherosclerosis	5.31e-05	0.000336	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GPX1—atherosclerosis	5.25e-05	0.000333	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GHRL—atherosclerosis	5.19e-05	0.000329	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLAT—atherosclerosis	5.19e-05	0.000329	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PARP1—atherosclerosis	5.19e-05	0.000329	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CD36—atherosclerosis	5.11e-05	0.000324	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOS2—atherosclerosis	5.02e-05	0.000318	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—F2—atherosclerosis	4.99e-05	0.000316	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTHFR—atherosclerosis	4.84e-05	0.000307	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CXCL8—atherosclerosis	4.82e-05	0.000305	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CG—atherosclerosis	4.77e-05	0.000302	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPARA—atherosclerosis	4.75e-05	0.000301	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AGT—atherosclerosis	4.6e-05	0.000292	CbGpPWpGaD
Mimosine—SHMT1—Disease—INS—atherosclerosis	4.6e-05	0.000291	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KNG1—atherosclerosis	4.56e-05	0.000289	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AGTR1—atherosclerosis	4.53e-05	0.000287	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOE—atherosclerosis	4.51e-05	0.000286	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CAV1—atherosclerosis	4.47e-05	0.000283	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOA1—atherosclerosis	4.46e-05	0.000282	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLG—atherosclerosis	4.42e-05	0.00028	CbGpPWpGaD
Mimosine—SHMT1—Disease—SERPINE1—atherosclerosis	4.23e-05	0.000268	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SOCS3—atherosclerosis	4.18e-05	0.000265	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CG—atherosclerosis	4.07e-05	0.000258	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP3—atherosclerosis	4.04e-05	0.000256	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOS3—atherosclerosis	4.03e-05	0.000256	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IGF2—atherosclerosis	4.02e-05	0.000255	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPARG—atherosclerosis	3.93e-05	0.000249	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOB—atherosclerosis	3.9e-05	0.000247	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—INS—atherosclerosis	3.85e-05	0.000244	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EDN1—atherosclerosis	3.84e-05	0.000243	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL5—atherosclerosis	3.81e-05	0.000241	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LPL—atherosclerosis	3.73e-05	0.000236	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTGS2—atherosclerosis	3.69e-05	0.000234	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKCG—atherosclerosis	3.62e-05	0.00023	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALB—atherosclerosis	3.53e-05	0.000224	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SPP1—atherosclerosis	3.53e-05	0.000224	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL8—atherosclerosis	3.52e-05	0.000223	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NOS3—atherosclerosis	3.38e-05	0.000214	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFB—atherosclerosis	3.27e-05	0.000207	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AGT—atherosclerosis	3.19e-05	0.000202	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOE—atherosclerosis	3.12e-05	0.000198	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LEP—atherosclerosis	3.12e-05	0.000198	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CAV1—atherosclerosis	3.1e-05	0.000196	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS2—atherosclerosis	3.09e-05	0.000196	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOA1—atherosclerosis	3.09e-05	0.000196	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ESR1—atherosclerosis	2.98e-05	0.000189	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—F2—atherosclerosis	2.95e-05	0.000187	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT3—atherosclerosis	2.88e-05	0.000182	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CG—atherosclerosis	2.82e-05	0.000179	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK3—atherosclerosis	2.75e-05	0.000174	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK3—atherosclerosis	2.7e-05	0.000171	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—INS—atherosclerosis	2.67e-05	0.000169	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFB1—atherosclerosis	2.67e-05	0.000169	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IGF1—atherosclerosis	2.58e-05	0.000164	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SERPINE1—atherosclerosis	2.45e-05	0.000155	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOS3—atherosclerosis	2.34e-05	0.000148	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL8—atherosclerosis	2.08e-05	0.000132	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—atherosclerosis	2.01e-05	0.000127	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—atherosclerosis	1.97e-05	0.000125	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP9—atherosclerosis	1.88e-05	0.000119	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NFKB1—atherosclerosis	1.86e-05	0.000118	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—atherosclerosis	1.85e-05	0.000117	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK8—atherosclerosis	1.83e-05	0.000116	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—atherosclerosis	1.82e-05	0.000115	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—atherosclerosis	1.69e-05	0.000107	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—atherosclerosis	1.67e-05	0.000106	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK3—atherosclerosis	1.6e-05	0.000101	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—atherosclerosis	1.55e-05	9.84e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFB1—atherosclerosis	1.55e-05	9.81e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—atherosclerosis	1.17e-05	7.39e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—atherosclerosis	1.08e-05	6.82e-05	CbGpPWpGaD
